MRUS MERUS NV Investments/Divestments 8-K Filing 2023 - Clinical Development Updates Merus N.V. provides updates on the clinical development of petosemtamab, including interim clinical data and regulatory discussions with the FDA.Get access to all SEC 8-K filings of the MERUS NV